The Journal of Pharmaceutical Policy and Practice is the official journal of the Commonwealth Pharmacists Association.
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O26
Page 8 of 8
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O26
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O24
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O22
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O18
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P8
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):O8
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P6
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P4
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):I2
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):P2
Citation: Journal of Pharmaceutical Policy and Practice 2014 7(Suppl 1):I1
This study aimed to explore patients’ utilization of repeat prescriptions for antibiotics indicated in upper respiratory tract infections (URTI). An emphasis was placed on whether the current system of repeat ...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:17
Many low income countries struggle to provide safe and effective medicines due to poor public health care infrastructure, budgetary constraints, and lack of human resource capacity. Private sector pharmacies a...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:18
Death among tuberculosis patients is one of the major reasons for non-attainment of 85% treatment success target set by World Health Organization. In this short paper, we evaluated whether the overall mortalit...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:16
Adherence to treatment guidelines for uncomplicated malaria is critical to the success of malaria case management. Poor adherence has implications for increased malaria burden, in view of the risk of widesprea...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:15
To determine the incidence of symptomatic moderate-to-severe adverse events during treatment of drug-resistant tuberculosis, and to compare their risk and outcomes by patients’ human immunodeficiency virus (HI...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:14
The United Nations Relief and Works Agency for Palestine Refugees in the Near East (UNRWA), the main primary healthcare provider for 4.9 million Palestinian refugees, spent USD18.3 million on essential medicin...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:13
The rapid increase in drug expenditure has become a major source of public criticism in China. In 2009, the National Essential Medicine System (NEMS) was launched in China to control drug prices and improve ac...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:12
A public-private partnership in Tanzania launched the accredited drug dispensing outlet (ADDO) program to improve access to quality medicines and pharmaceutical services in rural areas. ADDO dispensers play a ...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:11
Do antimicrobial stewardship programs (ASPs) contribute to reduction of antimicrobial therapy costs in Japanese community hospitals? To answer this health economic question, a before-after comparative two-year...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:10
The United States and China are broadening health insurance coverage and increasing spending on pharmaceuticals, in contrast to other major economies that are reducing health spending and implementing a variet...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:9
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:8
The aim of this study was to investigate Jordanian physicians’ perception and attitudes toward generic medicines and generic substitution. It also aimed to examine factors that affect physicians’ pattern of pr...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:7
To analyze a sample of pharmaceutical waste drawn from household garbage in Vienna, with the aim to learn whether and which medicines end up unused in normal household waste.
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:6
Limited human resources are widely recognised as an impediment to achieving the health-related Millennium Development Goals in Pacific Island Countries, with the availability of medical supplies and suitably t...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:5
Regulation of the pharmaceutical system is a crucial, yet often neglected, component in ensuring access to safe and effective medicines. The aim of this study was to provide an in-depth analysis of the existin...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:4
Since 2004, the government of Tanzania has been rolling out antiretroviral treatment programs all over the country. However, the capacity of the health system to cope with the rapid scale-up of these programs ...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:3
Promoting generic medicines to increase access to essential medicines is relevant to achieve the Millennium Development Goal (MDGs) and post 2015 goals.
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:2
The aims of the study were to examine the association between immigrant background and medicine use for headache and stomach-ache among adolescents, and whether symptoms of headache and stomach-ache could expl...
Citation: Journal of Pharmaceutical Policy and Practice 2014 7:1
Clinical trials present an ethical dilemma for pharmaceutical companies. While companies may want to undertake and report these trials in an ethical manner, negative results can significantly affect product sa...
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:11
Chloroquine (CQ), after 67 years of use in Haiti, is still part of the official treatment policy for malaria. Several countries around the world have used CQ in the past due to its low incidence of adverse eve...
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:10
Antibacterial drugs (hereafter referred to as antibiotics) are crucial to treat infections during delivery and postpartum period to reduce maternal mortality. Institutional deliveries have the potential to sav...
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:9
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:8
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:7
The present survey was conducted to investigate the price and availability of a basket of 24 essential antibiotics and eight high-end antibiotics at various levels of health care in public and private sector i...
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:6
Continuous provision of appropriate medicines of assured quality, in adequate quantities, and at reasonable prices is a concern for all national governments. A national medicines policy (NMP) developed in a co...
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:5
Bacterial meningitis is a medical emergency associated with high mortality rates. Cerebrospinal fluid (CSF) culture is the “gold standard” for diagnosis of meningitis and it is important to establish the susce...
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:4
The aim of this study was to explore Jordanian patients’ perceptions toward generic medicines and to evaluate their opinions regarding generic substitution.
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:3
The belief that all new medicines bring a therapeutic innovation and better health outcomes is widely shared among the public, health professionals and policy makers.
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:2
Citation: Journal of Pharmaceutical Policy and Practice 2013 6:1
The Journal of Pharmaceutical Policy and Practice is the official journal of the Commonwealth Pharmacists Association.
Speed
76 days to first decision for reviewed manuscripts only
64 days to first decision for all manuscripts
176 days from submission to acceptance
21 days from acceptance to publication
Citation Impact
1.158 - Source Normalized Impact per Paper (SNIP)
0.644 - SCImago Journal Rank (SJR)
2.8 - CiteScore
Usage
178,372 Downloads
295 Altmetric mentions